Merck Foundation Heightens Focus on Advancing Equity in Cardiac Care Across the U.S.
November 20, 2024 2:37 pm ET
RAHWAY, N.J., Nov. 20, 2024 – The Merck Foundation (Foundation), a private charitable organization funded by Merck (NYSE: MRK), known as MSD outside of the United States and Canada, is committing $17 million over five years (2025-2030) to support the Collaborative for Equity in Cardiac Care (Collaborative), a new initiative to help advance equitable access to high-quality care for people with heart conditions in underserved U.S. communities.
The Collaborative aims to:
- Transform the delivery of primary care by promoting person-centered approaches to meet the medical and social needs of people living with heart conditions;
- Build sustainable community partnerships to address barriers to cardiac care;
- Improve health outcomes and quality of life for people living with heart conditions;
- Disseminate findings and lessons learned to improve the delivery of cardiac care.
Through the Collaborative, the Foundation will work to advance health equity by investing in programs that help to build stronger health systems and address systemic barriers to care.
About the Merck Foundation
The Merck Foundation (Foundation) is a U.S.-based, private charitable organization. Established in 1957 by Merck, a leading global biopharmaceutical company, the Foundation is funded entirely by the company and is Merck’s chief source of funding support to qualified non-profit charitable organizations. Since its inception, the Foundation has contributed more than $1 billion to support important initiatives that address critical global health and societal needs that are consistent with Merck’s purpose: to save and improve lives around the world. For more information, visit merck.com/company-overview/sustainability/philanthropy/merck-foundation.
Media Contacts:
Robert Josephson
(203) 914-2372
